Viewing Study NCT06133556


Ignite Creation Date: 2025-12-24 @ 11:30 PM
Ignite Modification Date: 2026-05-22 @ 1:11 AM
Study NCT ID: NCT06133556
Status: NOT_YET_RECRUITING
Last Update Posted: 2023-11-15
First Post: 2023-09-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Conditioning Regimen Containing Melphalan and Cladribine for Refractory / Relapsed AML
Sponsor: Institute of Hematology & Blood Diseases Hospital, China
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Acute Myeloid Leukemia View
Keywords: